Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
| CAPS Rating |
|
|---|---|
| Open | $8.50 |
| Previous Close | $8.55 |
| Daily Range | $8.36 - $8.62 |
| 52-Week Range | $5.42 - $9.98 |
| Market Cap | $476.16M |
| P/E Ratio | 28.40 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 464,198 |
| Average Daily Volume | 0 |
NBIX
VS S&P 500 (SPY)
How do you think NBIX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
NBIX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
NBIX News and Commentary
- Neurocrine Biosciences Shares Dropped: What You Need to Know – The Motley Fool
- Profit Ideas: 10 High-Growth Stocks With Strong Sources of Profitability – The Motley Fool
- Our Top Biotech Stock Idea – The Motley Fool
- Make Money in Biotech and Genome Stocks the Easy Way – The Motley Fool
- 3 Stocks That Blew the Market Away – The Motley Fool
- Whoa! My Stock Crushed the Market! – The Motley Fool
- Avoid This Biotech Stock – The Motley Fool
- Insomnia Found to Cost $63 Billion a Year - Here are 4 Companies to Treat It – NASDAQ
- Brain Disorders: 3 Biotech Stocks at the Forefront – NASDAQ
- Neurocrine Biosciences' CEO Discusses Q2 2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Neurocrine Biosciences, Inc. CEO Discusses Q1 2011 Results - Earnings Call Transcript – SeekingAlpha
- Neurocrine Biosciences, Inc. CEO Discusses Q1 2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- 25 Small Caps With Sales and EPS Declining in 2012 – SeekingAlpha
- Neurocrine Biosciences Shares Popped: What You Need to Know – The Motley Fool
- 5 Earnings Studs & 5 Duds – NASDAQ
- Future Biotech Superstars – SeekingAlpha
- Rebound Ideas: 15 Cash-Rich Companies Seeing Bullish Technical Divergence – SeekingAlpha
- 6 Biotech Firms With Encouraging DuPont Breakdowns – SeekingAlpha
- Battered but Unbroken Biotechs – SeekingAlpha
- FDA Meeting Should Clarify Path For Neurocrine Bio's Efforts – SeekingAlpha
RSS Headlines
Fool UK
